Deep EigenMatics Tops 2025 Global AI Drug Discovery Patent Rankings

February 04, 2026
Deep EigenMatics has secured the top global ranking for new U.S. patent families in AI drug discovery methods for 2025, surpassing all major pharmaceutical companies in patent output during its first year of operation.

Deep EigenMatics has achieved the number one global ranking for new U.S. patent families in AI drug discovery methods for 2025, announced in a press release. The company, which began operations in 2025, secured four unique patent families covering its proprietary computational architectures for exploring chemical space.

The patents represent twice the combined output of all major pharmaceutical companies in the same category. Deep EigenMatics measured its performance using two internal metrics—Patent Family Volume and Innovation Velocity Index—indicating a high efficiency rate in its R&D operations.

Building on this momentum, the company has identified the Oral GLP-1 category as its lead therapeutic target. It plans to move into the execution phase for its Oral GLP-1 candidate, with a development roadmap extending through 2026 and 2027.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

02/04
Cognizant and Uniphore Partner on Industry-Specific AI Solutions
02/04
Presbyterian Healthcare Expands GW RhythmX AI Platform to 200 Clinicians
02/04
Virtual Science AI Launches Medical Congress AI for Real-Time Event Insights
02/02
Oracle Launches AI Data Platform for Life Sciences Research
02/02
XtalPi Introduces AI-Powered XGlue Platform for Molecular Glue Drug Discovery

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like